FDA Approves Oxbryta™ (Voxelotor), the First Medicine Specifically Targeting the Root Cause of Sickle Cell Disease – GlobeNewswire November 25, 2019 by Zennie Abraham FDA Approves Oxbryta™ (Voxelotor), the First Medicine Specifically Targeting the Root Cause of Sickle Cell Disease GlobeNewswire …read more Source:: Oakland, California News By Google News